NASDAQ:LFCR

Lifecore Biomedical Q1 2026 Earnings Results & Report

Lifecore Biomedical logo
$6.40 -0.02 (-0.23%)
As of 01:07 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Lifecore Biomedical beat analyst expectations on both earnings and revenue in its Q1 2026 results, released November 6, 2025. The company reported EPS of -$0.29 versus the -$0.30 consensus estimate, while revenue of $31.11 million topped the $26.68 million estimate by $4.43 million.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes
Conference Call
7:00 AM ET

Lifecore Biomedical EPS Results

Actual EPS
-$0.29
Consensus EPS
-$0.30
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Lifecore Biomedical Revenue Results

Actual Revenue
$31.11 million
Expected Revenue
$26.68 million
Beat/Miss
Beat by +$4.43 million
YoY Revenue Growth
N/A

Earnings Documents

Lifecore Biomedical Q1 2026 Earnings FAQ

Lifecore Biomedical (NASDAQ:LFCR) reported earnings of -$0.29 per share for Q1 2026, beating the consensus estimate of -$0.30. The report was announced on Thursday, November 6, 2025.

Lifecore Biomedical reported revenue of $31.11 million for Q1 2026, against a consensus estimate of $26.68 million.

Lifecore Biomedical Earnings Headlines

Lifecore Biomedical Inc.
I'm handing you this stock today
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public company. Now he's planning 1,000,000 AI satellites in orbit, and every one could pay this company a royalty. Analyst Dylan says the window to get in closes around December 8th, before new money floods into the buildout.tc pixel
See More Lifecore Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Lifecore Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lifecore Biomedical and other key companies, straight to your email.

About Lifecore Biomedical

Lifecore Biomedical (NASDAQ:LFCR) is a contract development and manufacturing organization (CDMO) focused on sterile injectable pharmaceutical products. The company works with customers on product development, formulation, analytical testing, regulatory support and commercial-scale manufacturing, including fill-finish services.

Lifecore also develops and manufactures hyaluronic acid, a biopolymer used in medical products and other applications. Its capabilities support products in areas such as ophthalmology and orthopedics, as well as pharmaceutical and veterinary uses.

Based in Chaska, Minnesota, Lifecore serves pharmaceutical and medical technology companies in the United States and internationally. The business has a history in hyaluronic acid production and has expanded its role as a CDMO serving customers from development through commercial manufacturing.

View Lifecore Biomedical Profile